Eli Lilly and Co (NYSE:LLY)
| 222.33 Delayed Data As of 4:00pm ET |  +1.57 / +0.71%Today’s Change | 129.21 Today|||52-Week Range 235.85 | +31.68% Year-to-Date |
Latest LLY News | Press Releases
Today’s Trading
| Previous close | 220.76 |
| Today’s open | 223.13 |
| Day’s range | 220.67 - 223.14 |
| Volume | 1,891,008 |
| Average volume (3 months) | 3,534,131 |
| Market cap | $214.9B |
Data as of 4:00pm ET, 06/17/2021
Growth & Valuation
| Earnings growth (last year) | +36.99% |
| Earnings growth (this year) | +0.04% |
| Earnings growth (next 5 years) | +12.30% |
| Revenue growth (last year) | +9.95% |
| P/E ratio | 33.3 |
| Price/Sales | 6.28 |
| Price/Book | 38.00 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck | +0.59 | +0.78% |
| NVSNovartis | +0.20 | +0.21% |
| ABBVAbbVie | -0.62 | -0.54% |
| PFEPfizer | +0.17 | +0.43% |
Data as of 4:47pm ET, 06/17/2021
Financials
| Next reporting date | August 3, 2021 |
| EPS forecast (this quarter) | $1.92 |
| Annual revenue (last year) | $24.5B |
| Annual profit (last year) | $6.2B |
| Net profit margin | 25.24% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |
Forecasts
